Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Bacterial Skin and Skin Structure Infection (ABSSSI)”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Post-approval studies (Phase 4)Study completedNCT02582203
What this trial is testing

Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA

Who this might be right for
Skin Diseases, InfectiousStaphylococcal Skin Infections
Wayne State University 174
Large-scale testing (Phase 3)Study completedNCT02814916
What this trial is testing

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

Who this might be right for
Methicillin-Resistant Staphylococcus AureusBacterial InfectionsStaphylococcal Skin Infections
AbbVie 199
Testing effectiveness (Phase 2)Study completedNCT02052388
What this trial is testing

Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections

Who this might be right for
Skin InfectionBacterial Infection
Cellceutix Corporation 215
Testing effectiveness (Phase 2)Study completedNCT02269319
What this trial is testing

MRX-I Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection

Who this might be right for
Bacterial Infections
MicuRx 120
Large-scale testing (Phase 3)Study completedNCT02066402
What this trial is testing

Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Who this might be right for
Bacterial Infections
Bayer 598
Post-approval studies (Phase 4)Study completedNCT03233438
What this trial is testing

Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Who this might be right for
Bacterial InfectionsAcute Bacterial Skin and Skin Structure Infection
Allergan 91
Testing effectiveness (Phase 2)Study completedNCT01119105
What this trial is testing

Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Who this might be right for
Bacterial InfectionsInfection
Nabriva Therapeutics AG 210
Large-scale testing (Phase 3)Study completedNCT03405064
What this trial is testing

Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Who this might be right for
Acute Bacterial Skin and Skin Structure Infections
Wockhardt 501
Large-scale testing (Phase 3)Study completedNCT02877927
What this trial is testing

Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI

Who this might be right for
Bacterial InfectionsSkin Structures and Soft Tissue Infections
Paratek Pharmaceuticals Inc 735
Post-approval studies (Phase 4)Study completedNCT02961764
What this trial is testing

Evaluation of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Who this might be right for
Acute Bacterial Skin and Skin Structure Infections
Allergan 313
Large-scale testing (Phase 3)Study completedNCT01252719
What this trial is testing

Oritavancin Versus IV Vancomycin for the Treatment of Participants With Acute Bacterial Skin and Skin Structure Infection (SOLO I)

Who this might be right for
Wound InfectionAbscessSystemic Inflammation+1 more
Melinta Therapeutics, Inc. 968
Not applicableStudy completedNCT04298463
What this trial is testing

Retrospective Effectiveness Study of Dalbavancin and Other Standard of Care of the Same Class in Patients With ABSSSI

Who this might be right for
Acute Bacterial Skin and Skin Structure Infection
Aziende Chimiche Riunite Angelini Francesco S.p.A 184
Testing effectiveness (Phase 2)Study completedNCT00949130
What this trial is testing

Comparative Study of NXL103 Versus Linezolid in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Who this might be right for
Acute Bacterial Skin and Skin Structure Infections
Novexel Inc 180
Testing effectiveness (Phase 2)Study completedNCT03964493
What this trial is testing

TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection

Who this might be right for
Skin and Subcutaneous Tissue Bacterial InfectionsGram-Positive Bacterial Infections
TenNor Therapeutics Limited 120
Testing effectiveness (Phase 2)UnknownNCT03732365
What this trial is testing

Phase 2 Randomized Study to Compare Ultrasonic Drug Delivery to Standard of Care for the Treatment of Infections in Non-Healing Wounds

Who this might be right for
Acute Bacterial Skin and Skin Structure Infection (ABSSSI)Non-healing Wound
Sonescence, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT03747497
What this trial is testing

Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection

Who this might be right for
Skin Diseases, BacterialGram-Positive Bacterial Infections
MicuRx 196
Large-scale testing (Phase 3)Study completedNCT01984684
What this trial is testing

Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Who this might be right for
Skin and Subcutaneous Tissue Bacterial InfectionsSkin Structures and Soft Tissue Infections
Melinta Therapeutics, Inc. 850
Testing effectiveness (Phase 2)Study completedNCT01211470
What this trial is testing

Initial Treatment for Acute Bacterial Skin Infections (ABSSSI) Caused by Staphylococcus Aureus

Who this might be right for
Acute Bacterial Skin and Skin-structure Infection(ABSSSI) Due to Staphylococcus Aureus (MSSA)(Susceptible or Methicillin Resistant)
PolyMedix, Inc. 215
Post-approval studies (Phase 4)Study completedNCT02452918
What this trial is testing

Evaluate the Safety of a Single Intravenous (IV) Dose of Orbactiv (Oritavancin) in Participants on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Who this might be right for
Acute Bacterial Skin and Skin Structure Infection
The Medicines Company 17
Post-approval studies (Phase 4)Study completedNCT02925416
What this trial is testing

Safety of Either a Single or Two Intravenous Doses of Orbactiv in Participants With Acute Bacterial Skin and Skin Structure Infection

Who this might be right for
Skin Diseases, Bacterial
The Medicines Company 22
Next Page